Impact of Cytogenetics on Outcome of De novo and Therapy-related AML and MDS after Allogeneic Transplantation

Cytogenetics has an important impact on the prognosis of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) for AML or MDS. However, it is unclear whether currently accepted cytogenetic risk groups, which were established for patients treated mostly with standard therapy,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Armand, Philippe, Kim, Haesook T., DeAngelo, Daniel J., Ho, Vincent T., Cutler, Corey S., Stone, Richard M., Ritz, Jerome, Alyea, Edwin P., Antin, Joseph H., Soiffer, Robert J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2007
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2743535/
https://ncbi.nlm.nih.gov/pubmed/17531775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2007.01.079
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi